Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-Agent: * Allow: |
Title | Multiple Myeloma |
Description | EXPANDING THE HORIZON IN RELAPSED OR REFRACTORY MULTIPLE Learn about the need for additional treatment for advanced cases of relapsed/refractory multiple myeloma. See how BCMA and CD3 therapies can be new targets for |
Keywords | N/A |
WebSite | multiplemyelomahorizon.com |
Host IP | 54.192.99.52 |
Location | United States |
Site | Rank |
US$279,187
Last updated: 2023-05-19 17:25:09
multiplemyelomahorizon.com has Semrush global rank of 37,911,163. multiplemyelomahorizon.com has an estimated worth of US$ 279,187, based on its estimated Ads revenue. multiplemyelomahorizon.com receives approximately 32,214 unique visitors each day. Its web server is located in United States, with IP address 54.192.99.52. According to SiteAdvisor, multiplemyelomahorizon.com is safe to visit. |
Purchase/Sale Value | US$279,187 |
Daily Ads Revenue | US$258 |
Monthly Ads Revenue | US$7,732 |
Yearly Ads Revenue | US$92,776 |
Daily Unique Visitors | 2,148 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
multiplemyelomahorizon.com. 1799 IN | A | IP: d17txsccua3df7.cloudfront.net. | |
d17txsccua3df7.cloudfront.net. 58 IN | A | IP: 54.192.99.52 | |
d17txsccua3df7.cloudfront.net. 58 IN | A | IP: 54.192.99.53 | |
d17txsccua3df7.cloudfront.net. 58 IN | A | IP: 54.192.99.120 | |
d17txsccua3df7.cloudfront.net. 58 IN | A | IP: 54.192.99.115 | |
multiplemyelomahorizon.com. 1798 IN | AAAA | IPV6: d17txsccua3df7.cloudfront.net. | |
multiplemyelomahorizon.com. 1798 IN | NS | NS Record: d17txsccua3df7.cloudfront.net. | |
d17txsccua3df7.cloudfront.net. 7199 IN | NS | NS Record: ns-968.awsdns-57.net. | |
d17txsccua3df7.cloudfront.net. 7199 IN | NS | NS Record: ns-385.awsdns-48.com. | |
d17txsccua3df7.cloudfront.net. 7199 IN | NS | NS Record: ns-1867.awsdns-41.co.uk. | |
d17txsccua3df7.cloudfront.net. 7199 IN | NS | NS Record: ns-1067.awsdns-05.org. | |
multiplemyelomahorizon.com. 1798 IN | MX | MX Record: d17txsccua3df7.cloudfront.net. | |
multiplemyelomahorizon.com. 1797 IN | TXT | TXT Record: d17txsccua3df7.cloudfront.net. |
The Challenge The Target Share Sign Up Sign Up! EXPANDING THE HORIZON IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA Relapsed or refractory multiple myeloma is a complex disease, the treatment of which would benefit from further study and investigation. There remains a critical need for new approaches in later lines. 1 Treating advanced cases in relapsed or refractory multiple myeloma remains a significant challenge There remains a need for improved treatment options for patients with relapsed or refractory multiple myeloma, including those who have progressed following treatment with multiple classes of drugs. As multiple myeloma progresses, relapses become more aggressive with each line of therapy, and remissions become progressively shorter. 1-7 Triple class refractory disease occurs when patients relapse on or are refractory to one proteasome inhibitor, one immunomodulatory agent, and one anti-CD38 monoclonal antibody. 8-11 Proteasome Inhibitors Immunomodulatory Agents Anti-CD38 |
HTTP/1.1 301 Moved Permanently Server: CloudFront Date: Wed, 02 Nov 2022 08:49:48 GMT Content-Type: text/html Content-Length: 167 Connection: keep-alive Location: https://multiplemyelomahorizon.com/ X-Cache: Redirect from cloudfront Via: 1.1 350f2b5d7e6ee985da330b123098fd88.cloudfront.net (CloudFront) X-Amz-Cf-Pop: ARN1-C1 X-Amz-Cf-Id: 641PMv-Nv00iU-CNke1sDLcb7pk4ksXOJFj-M9QQmS8N0GaQpY7-1g== X-XSS-Protection: 1; mode=block X-Frame-Options: SAMEORIGIN Referrer-Policy: same-origin Content-Security-Policy: default-src *; script-src * 'unsafe-eval' 'self' 'unsafe-inline' https:; style-src * 'unsafe-inline'; object-src 'self' *.youtube.com youtube.com; img-src * data:; frame-src *; font-src * data:; connect-src *; media-src * blob:; worker-src 'self' blob:; X-Content-Type-Options: nosniff HTTP/1.1 200 OK Content-Type: text/html Content-Length: 80722 Connection: keep-alive Date: Wed, 02 Nov 2022 08:49:49 GMT Cache-Control: max-age=3600 Last-Modified: Wed, 17 Aug 2022 15:39:14 GMT ETag: "a177a5e01270182069b90b143aebde75" Server: AmazonS3 X-Cache: Miss from cloudfront Via: 1.1 8ea75fde43c768e7e1d041f8b7a07bd6.cloudfront.net (CloudFront) X-Amz-Cf-Pop: ARN56-P1 X-Amz-Cf-Id: 99RwOo7LR9godPfT_pFVNLdMoQ0PX3nXwcX9AaIY4jyr6tQ1j9w1Dw== X-XSS-Protection: 1; mode=block X-Frame-Options: SAMEORIGIN Referrer-Policy: same-origin Content-Security-Policy: default-src *; script-src * 'unsafe-eval' 'self' 'unsafe-inline' https:; style-src * 'unsafe-inline'; object-src 'self' *.youtube.com youtube.com; img-src * data:; frame-src *; font-src * data:; connect-src *; media-src * blob:; worker-src 'self' blob:; X-Content-Type-Options: nosniff Strict-Transport-Security: max-age=63072000; includeSubDomains; preload |
Domain Name: MULTIPLEMYELOMAHORIZON.COM Registry Domain ID: 2683188072_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.rrpproxy.net Registrar URL: http://www.key-systems.net Updated Date: 2022-03-21T14:19:27Z Creation Date: 2022-03-21T14:19:22Z Registry Expiry Date: 2023-03-21T14:19:22Z Registrar: Key-Systems GmbH Registrar IANA ID: 269 Registrar Abuse Contact Email: abuse@key-systems.net Registrar Abuse Contact Phone: +49.68949396850 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.JNJ.COM Name Server: NS3.JNJ.COM Name Server: NS5.JNJ.COM DNSSEC: unsigned >>> Last update of whois database: 2022-11-02T08:52:45Z <<< |